학술논문

Randomized phase 2 study of the safety, efficacy, and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR).
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2016, 34 15, 2p. Supplement: S
Subject
Language
English
ISSN
15277755